Bosutinib - CAS# 380843-75-4 287 It is a component of

It is a component of tegafur-uracil

WO2012024404A1

Smiles: CC1=C(C=C2SC(=O)N(C3C=CC=CC=3)C2=O)C=C(C)N1C1=CN=CC=C1

Synthesized compounds from ceanothic acid have been shown to inhibit Epstein-Barr virus early antigen activation in anti-cancer research

and patient mortality

Bosutinib - CAS# 380843-75-4 287 It is a component ofBosutinib, also known as SKI 606, is a synthetic quinolone derivative and dual kinase inhibitor that targets both Abl and Src kinases with potential antineoplastic activity. Unlike imatinib, bosutinib inhibits the autophosphorylation of both Abl and Src kinases, resulting in inhibition of cell growth and apoptosis. Because of the dual mechanism of action, this agent may have activity in resistant CML disease, other myeloid malignancies and solid